The pilot program — which drew a legal challenge from the hospital industry — would have required providers in the program to ...

NEW YORK (AP) — The Trump administration on Thursday will launch TrumpRx, a website it says will help patients buy ...

After Mamdani won the primary, Wylde pushed to stay on beyond the end of the year; the Partnership board said no and ...

Rheumatologists share how they are using AI platforms for clinical documentation, reducing EHR time, streamlining workflows, ...

CANOPY reports seven strategies for 2026 to combat workplace burnout and improve mental health, emphasizing hybrid models, ...

Although it is the leading infectious cause of birth defects, patients and some doctors know little about cytomegalovirus.

Robert F. Kennedy’s position on vaccines is profoundly "anti-science" and making progress would require a new health secretary, Pfizer Chief Executive Albert Bourla said Wednesday. “I have very ...

Pfizer Inc. (NYSE: PFE) disclosed the death of a participant in a long-term open-label extension study of marstacimab in patients with hemophilia A or B. In October 2024, the FDA approved Pfizer’s ...

A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several hemophilia advocacy groups confirmed this week. Pfizer is now working with its ...

Pfizer is reiterated as a 'Hold' due to structural challenges, despite a recent 12% total return and a compelling 6.7% dividend yield. PFE faces a significant patent cliff by 2028, high leverage, and ...

Pfizer CEO Albert Bourla called vaccine skepticism in the highest levels of the federal government “an anomaly” during an investor call on Tuesday.

Pfizer Inc. (NYSE: PFE) is scheduled to provide its full-year 2026 financial guidance on Tuesday, with Bank of America Securities expecting the company's growth profile to closely resemble conditions ...